| Name and reference of original method: |
-
•
B.L. Ferry, S.A. Misbah, P. Stephens, Z. Sherrell, H. Lythgoe, E. Bateman, C. Banner, J. Jones, N. Groome, H.M. Chapel, Development of an anti-Salmonella typhi Vi ELISA: assessment of immunocompetence in healthy donors, Clin. Exp. Immunol. 136 (2004) 297–303. https://doi.org/10.1111/j.1365-2249.2004.02439.x.
-
•
S. Sánchez-Ramón, J. de Gracia, Am. García-Alonso, J.J. Rodríguez Molina, J. Melero, A. de Andrés, J.M. García Ruiz de Morales, A. Ferreira, J.G. Ocejo-Vinyals, J.J. Cid, J.M. García Martínez, T. Lasheras, M.L. Vargas, J. Gil-Herrera, M.C. García Rodríguez, J.L. Castañer, L.I. González Granado, L.M. Allende, P. Soler-Palacin, L. Herráiz, M. López Hoyos, J.M. Bellón, G. Silva, D.M. Gurbindo, J. Carbone, C. Rodríguez-Sáinz, N. Matamoros, A.R. Parker, E. Fernández-Cruz, Multicenter study for the evaluation of the antibody response against salmonella typhi Vi vaccination (EMPATHY) for the diagnosis of Anti -polysaccharide antibody production deficiency in patients with primary immunodeficiency, Clin. Immunol. 169 (2016) 80–84. https://doi.org/10.1016/j.clim.2016.05.006.
-
•
M.T. Bausch-Jurken, J.W. Verbsky, K.A. Gonzaga, N.P. Elms, M.K. Hintermeyer, S.B. Gauld, J.M. Routes, The Use of Salmonella Typhim Vaccine to Diagnose Antibody Deficiency, J. Clin. Immunol. 37 (2017) 427–433. https://doi.org/10.1007/s10875-017-0406-6.
-
•
H. Schaballie, B. Bosch, R. Schrijvers, M. Proesmans, K. De Boeck, M.N. Boon, F. Vermeulen, N. Lorent, D. Dillaerts, G. Frans, L. Moens, I. Derdelinckx, W. Peetermans, B. Kantsø, C.S. Jørgensen, M.-P. Emonds, X. Bossuyt, I. Meyts, Fifth Percentile Cutoff Values for Antipneumococcal Polysaccharide and Anti-Salmonella typhi Vi IgG Describe a Normal Polysaccharide Response, Front. Immunol. 8 (2017). https://doi.org/10.3389/fimmu.2017.00546.
-
•
J. Kumarage, S.L. Seneviratne, V. Senaratne, A. Fernando, K. Gunasekera, B. Gunasena, P. Gurugama, S. Peiris, A.R. Parker, S. Harding, N.R. de Silva, The response to Typhi Vi vaccination is compromised in individuals with primary immunodeficiency, Heliyon. 3 (2017) e00333. https://doi.org/10.1016/j.heliyon.2017.e00333.
-
•
I. Unal, Defining an Optimal Cut-Point Value in ROC Analysis: An Alternative Approach, Comput. Math. Methods Med. 2017 (2017) 1–14. https://doi.org/10.1155/2017/3762651.
|
